Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Progyny (PGNY) Shares Issued (2018 - 2025)

Progyny (PGNY) has disclosed Shares Issued for 8 consecutive years, with $63000.0 as the latest value for Q4 2025.

Quarterly Shares Issued fell 68.97% to $63000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86000.0 through Dec 2025, down 93.38% year-over-year, with the annual reading at $86000.0 for FY2025, 93.38% down from the prior year.
Shares Issued for Q4 2025 was $63000.0 at Progyny, up from -$537000.0 in the prior quarter.
The five-year high for Shares Issued was $1.7 million in Q1 2023, with the low at -$2.2 million in Q3 2023.
Average Shares Issued over 5 years is $337000.0, with a median of $398500.0 recorded in 2022.
Peak annual rise in Shares Issued hit 333.94% in 2023, while the deepest fall reached 386.96% in 2023.
Over 5 years, Shares Issued stood at $1.2 million in 2021, then tumbled by 65.58% to $403000.0 in 2022, then dropped by 2.23% to $394000.0 in 2023, then tumbled by 48.48% to $203000.0 in 2024, then crashed by 68.97% to $63000.0 in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at $63000.0, -$537000.0, and $521000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.